GlassScriptPhysician profile
Arthur Herbert Herpolsheimer
NPI 1528043825
$2,929.70
in general payments reported to CMS, 2019-2025
42 companies · $452 in 2025
The $452 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $399 · 2021: $412 · 2022: $290 · 2023: $710 · 2024: $188 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,164 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,164.01 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $620.36 | 2019-2023 | |
| Astellas Pharma US INC | $251.18 | 2023 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $190.28 | 2022-2025 | |
| Minerva Surgical, INC | $166.58 | 2023-2025 | |
| Hologic Sales and Service, LLC | $156.71 | 2019-2025 | Myosure Tissue Removal Device, Omni Hysteroscope, Aptima |
| Coopersurgical, INC. | $147.53 | 2019-2025 | Onetrac Lx, Paragard T 380a |
| Therapeuticsmd, INC. | $132.32 | 2019-2022 | |
| Daiichi Sankyo INC. | $116.81 | 2019-2024 | Injectafer |
| Avion Pharmaceuticals | $81.61 | 2019-2021 | |
| Exeltis, USA INC. | $76.57 | 2020-2021 | |
| Sage Therapeutics, LLC | $58.47 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $53.37 | 2021-2022 | |
| Organon LLC | $51.24 | 2022-2024 | Nexplanon |
| Viiv Healthcare Company | $50.15 | 2023 | Apretude |
| Sumitomo Pharma America, INC. | $49.99 | 2024-2025 | Myfembree |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $45.73 | 2019-2023 | Gardasil 9 |
| Shield Therapeutics INC | $43.93 | 2024-2025 | |
| Myovant Sciences INC. | $41.08 | 2021-2022 | |
| Millicent US INC | $40.83 | 2025 | Femlyv |
| Medtronic, INC. | $40.16 | 2023 | Truclear |
| Baxter Healthcare | $39.91 | 2020 | |
| Axonics, INC. | $39.82 | 2021-2023 | Bulkamid, Axonics |
| Amag Pharmaceuticals, INC. | $38.42 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.34 | 2021-2025 | |
| Pfizer INC. | $34.79 | 2020-2022 | |
| Allergan, INC. | $34.02 | 2019 | |
| Qiagen, LLC | $33.56 | 2025 | |
| Biom'Up Sa | $27.30 | 2019 | |
| Lupin INC. | $26.23 | 2019-2020 | |
| Duchesnay USA Incorporated | $20.98 | 2019 | |
| Agile Therapeutics, INC. | $17.42 | 2022 | |
| Medicomp INC | $17.42 | 2019 | |
| Aspira Women'S Health INC | $17.35 | 2024 | Ova1 |
| Mallinckrodt Enterprises LLC | $16.32 | 2019 | |
| Covidien LP | $15.37 | 2020 | |
| Dysis Medical, INC. | $14.94 | 2021 | |
| Solventum Corporation | $14.84 | 2025 | Prevena |
| Gynesonics, INC. | $14.34 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Ethicon US, LLC | $14.27 | 2019 | |
| Medicem INC. | $13.95 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $13.36 | 2023 | Bd Onclarity |
| Kowa Pharmaceuticals America, INC. | $12.85 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Herpolsheimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.